Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations
Hugo C. Turner, James E. Truscott, Alison A. Bettis, et al.
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
Jaspreet Toor, Ramzi Alsallaq, James E. Truscott, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S245-S252
Open Access | Times Cited: 100
Schistosomiasis Control: Leave No Age Group Behind
Christina L. Faust, Derick Nii Mensah Osakunor, Jennifer A. Downs, et al.
Trends in Parasitology (2020) Vol. 36, Iss. 7, pp. 582-591
Open Access | Times Cited: 91
Tailoring Water, Sanitation, and Hygiene (WASH) Targets for Soil-Transmitted Helminthiasis and Schistosomiasis Control
Suzy J. Campbell, Nana‐Kwadwo Biritwum, Geordie Woods, et al.
Trends in Parasitology (2017) Vol. 34, Iss. 1, pp. 53-63
Open Access | Times Cited: 75
The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
Jaspreet Toor, Hugo C. Turner, James E. Truscott, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 10, pp. e0006717-e0006717
Open Access | Times Cited: 61
The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni
Gilmara Lima Nascimento, Helio Milani Pegado, Ana Lúcia Coutinho Domingues, et al.
Memórias do Instituto Oswaldo Cruz (2019) Vol. 114
Open Access | Times Cited: 48
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
Klodeta Kura, Diepreye Ayabina, Jaspreet Toor, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 3, pp. 236-244
Open Access | Times Cited: 36
Understanding perceptions of schistosomiasis and its control among highly endemic lakeshore communities in Mayuge, Uganda
Lazaaro Mujumbusi, Edith Nalwadda, Agnes Ssali, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 1, pp. e0010687-e0010687
Open Access | Times Cited: 13
Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance
Moses Adriko, Christina L. Faust, Lauren V. Carruthers, et al.
Tropical Medicine and Infectious Disease (2018) Vol. 3, Iss. 4, pp. 111-111
Open Access | Times Cited: 44
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
Jaspreet Toor, David Rollinson, Hugo C. Turner, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_5, pp. S525-S530
Open Access | Times Cited: 37
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
Klodeta Kura, Diepreye Ayabina, T. Déirdre Hollingsworth, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?
Klodeta Kura, Nyamai Mutono, María‐Gloria Basáñez, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S126-S130
Open Access | Times Cited: 4
Towards elimination of schistosomiasis after 5000 years of endemicity in Egypt
Iman F. Abou-El-Naga
Acta Tropica (2018) Vol. 181, pp. 112-121
Closed Access | Times Cited: 36
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis
Luc E. Coffeng, Matthew Graham, Raiha Browning, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S153-S159
Open Access | Times Cited: 3
Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique
Anna E. Phillips, Pedro Henrique Gazzinelli-Guimarães, Herminio O. Aurelio, et al.
PLoS neglected tropical diseases (2017) Vol. 11, Iss. 12, pp. e0006061-e0006061
Open Access | Times Cited: 29
SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
Matthew Graham, Diepreye Ayabina, Tim Lucas, et al.
Infectious Disease Modelling (2021) Vol. 6, pp. 438-447
Open Access | Times Cited: 23
Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?
Hugo C. Turner, Wilma A. Stolk, Anthony W. Solomon, et al.
BMJ Global Health (2021) Vol. 6, Iss. 8, pp. e005456-e005456
Open Access | Times Cited: 20
Comparative study of excretory–secretory proteins released by Schistosoma mansoni-resistant, susceptible and naïve Biomphalaria glabrata
Conor E. Fogarty, Min Zhao, Donald P. McManus, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
Jaspreet Toor, James E. Truscott, Marleen Werkman, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Progress in controlling the transmission of schistosome parasites in Southern Ethiopia: the Geshiyaro Project in the Wolaita Zone
Birhan Mengistu, Ewnetu Firdawek Liyew, Melkie Chernet, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone
Ibrahim Kargbo-Labour, Victoria Redwood-Sawyerr, Abdulai Conteh, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
Hugo C. Turner, Michael D. French, Antonio Montresor, et al.
Wellcome Open Research (2020) Vol. 5, pp. 45-45
Open Access | Times Cited: 17
Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
Hugo C. Turner, Michael D. French, Antonio Montresor, et al.
Wellcome Open Research (2020) Vol. 5, pp. 45-45
Open Access | Times Cited: 17
Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis
Danielle M. Cribb, Naomi E. Clarke, Suhail A.R. Doi, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 10, pp. e0007808-e0007808
Open Access | Times Cited: 17
Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
Benjamin Collyer, Hugo C. Turner, T. Déirdre Hollingsworth, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana
Lucas J. Cunningham, Suzy J. Campbell, Samuel Armoo, et al.
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 4, pp. e0007973-e0007973
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top